Navigation Links
Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009
Date:2/17/2009

VE EXPENSES 13,282,421 10,311,750 26,634,396 17,133,166 INCOME FROM OPERATIONS 11,425,697 8,483,150 18,772,853 13,417,584 OTHER (INCOME) EXPENSE: Other (income) expense, net 429,559 (40,185) 1,344,529 (27,507) Other (income) expense - related parties (92,774) (26,944) (236,724) (53,436) Non-operating (income) expense (225,558) (59,606) (150,937) 297 Interest expense, net 1,549,331 339,484 2,902,125 399,484 Loss from Discontinued Operations 1,545,607 112,931 1,590,823 112,931 OTHER EXPENSE, NET 3,206,165 325,680 5,449,816 431,769 INCOME BEFORE PROVISION FOR INCOME TAXES 8,219,532 8,157,470 13,323,037 12,985,815 PROVISION FOR INCOME TAXES 2,820,346 3,004,007 4,790,367 4,597,360 NET INCOME 5,399,186 5,153,463 8,532,670 8,388,455 OTHER COMPREHENSIVE INCOME: Unrealized Holding (loss) gain (384,650) 1,618,203 (1,947,617) 1,618,203 Foreign currency Translation Adjustment 248,823 1,050,485 579,464 1,467,831 COMPREHENSIVE INCOME $5,263,359 $7,822,151 $7,164,517 $11,474,489 BASIC WEIGHTED AVERAGE NUMBER OF SHARES 9,771,883 9,641,742 9,770,615 5,907,192 BASIC EARNINGS PER SHARE $0.55 $0.53 $0.87 $1.42 DILUTED WEIGHTED AVERAGE NUMBER OF SHARES 10,418,317 10,206,553 10,443,463 6,472,003 DILUTED EARNINGS PER SHARE $0.11 $0.02 $0.41 $0.53 GENESIS PHARMACEUTICALS ENTERPRISES, INC. AND SUBSIDIARIE
'/>"/>
SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009
2. Genesis HealthCare Promotes Wendy LaBate To Senior Vice President of Operations for the Northeast Area
3. AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
4. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
5. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
6. OmegaGenesis Announces Angiogenesis Application Collaboration
7. Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
8. Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
9. Cardiogenesis Reports Third Quarter 2008 Results
10. ThermoGenesis Presentation at Rodman & Renshaw Conference
11. Genesis Pharmaceuticals Launches New Corporate Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Follow us on LinkedIn ... has groomed and nurtured anti-aging products and technologies ... on appearance maintenance is benefitting the market for ... obtained from the bacterium, Clostridium Botulinum, which arrests ... With cosmetic indications for botulinum toxin ranging from ...
(Date:9/22/2014)... (Nasdaq: NEOG ) announced today that net ... year, which ended Aug. 31, was $8,883,000 — a ... the first quarter of last year. Adjusted for a ... share in the current quarter were $0.24, compared to ... increased 15% to $67,599,000, from the previous year,s first ...
(Date:9/22/2014)... Olso, Norway (PRWEB) September 22, 2014 ... convenient new parcel and pallet measuring device ... ScanTape™ eliminates manual data entry, offering greater ease ... time savings that result can significantly enhance productivity—an ... in industries where processing volume equals profits. ...
(Date:9/21/2014)... For the first time, scientists have discovered how to ... strength and stiffness greater than that of today,s strongest ... a research team led by John V. Badding, a ... published in the 21 September 2014 issue of the ... point of view, our discovery is intriguing because the ...
Breaking Biology Technology:Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7ScanTape™ Handheld Dimensioner Increases Processing Volume 2Smallest possible diamonds form ultra-thin nanothreads 2Smallest possible diamonds form ultra-thin nanothreads 3Smallest possible diamonds form ultra-thin nanothreads 4
... Inc.,(Nasdaq: VTIV ) today announced that Eran ... Officer, will make a presentation at the,2008 UBS ... which will,be held February 11-13, 2008. The conference ... management presentations and,extensive Q&A opportunities., inVentiv,s presentation ...
... Services to Unprecedented Number of ... Elderly and Bariatric Patients, MALVERN, Pa., Feb. 4 ... the first facility in the United,States to install the ... (http://www.usa.siemens.com/healthcare ) -- the,MAGNETOM(R) Verio. Combining 3 Tesla ...
... Chantix and Cialis Lead, Many Heavily Advertised Brands ... Manhattan Research, a leader in,syndicated research and marketing ... the top pharmaceutical branded,product websites ranked by offline ... are based on the comprehensive online consumer,research study ...
Cached Biology Technology:inVentiv Health to Present at the 2008 UBS Global Healthcare Services Conference 2Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 2Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 3Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates 2
(Date:9/21/2014)... Stanford researchers has developed a protein therapy that disrupts ... from original tumor sites, travel through the blood stream ... , This process, known as metastasis, can cause cancer ... of patients who succumb to cancer fall prey to ... associate professor of bioengineering who describes a new therapeutic ...
(Date:9/19/2014)... resource unveiled today by researchers from several Harvard ... provides both experienced and aspiring researchers with the ... operate robots made from soft, flexible materials. , ... cutters, and other advances in manufacturing technology, soft ... Using principles drawn from conventional rigid robot design, ...
(Date:9/19/2014)... A University of Oklahoma biology professor will study ... control leg movements with a National Science Foundation ... four-year project. , Ari Berkowitz, professor in the ... Sciences, will focus on the differences between the ... understand what neurotransmitters they use and what connections ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4Soft robotics 'toolkit' features everything a robot-maker needs 2
... of a human brain and squeeze it into a special chamber ... chamber filled with cerebral spinal fluid and thread both of them ... makes the neurons and other brain cells behave as if they ... battery of sensors that monitor how the cells respond when exposed ...
... special issue of ZooKeys , initiated by ... Vladimir Blagoderov bring together 18 papers by 81 authors to ... history collections. Centuries of exploration and discovery have documented ... biodiversity are, for the most part, distributed across varied ...
... discovered the structure and operating procedures of a ... alternative to antibiotics. In research published in ... Science USA, scientists from Monash University, The ... how the bacteriophage lysin, PlyC, kills bacteria that ...
Cached Biology News:Vanderbilt-led team to develop 'microbrain' to improve drug testing 2Vanderbilt-led team to develop 'microbrain' to improve drug testing 3Vanderbilt-led team to develop 'microbrain' to improve drug testing 4Vanderbilt-led team to develop 'microbrain' to improve drug testing 5Bringing natural history collections out of the dark 2New recruits in the fight against disease 2
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
... Buffer is a concentrated formulation of a ... capillary action technology, as well as for ... with David Brigati M.D., Department of Pathology, ... buffer is recommended for all the rinsing ...
...
... for users requiring mass detection but ... MALDI TOF Mass spectrometer is ideally ... and for high performance mass analysis. ... SNP analysis, protein detection, micro-satellite DNA ...
Biology Products: